We adopted a Bayesian
evidence-synthesis framework, expressing uncertainty in parameters through probability
distributions derived by fitting the model to prospectively collected laboratory-confirmed influenza
data from 2005-2009, by meta-analysis of clinical trial data, and by using prior probability
distributions derived from literature review and elicitation of expert opinion